Clinical trial Recruiting at 6 sites Interventional Ages 18 and up

Improving quality of life with pulmonary rehabilitation after pulmonary embolism

Official title: Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study

Run by University Hospital, Brest · NCT05015153 · Data updated 2026-11-12

This study is testing whether a structured pulmonary rehabilitation program can help adults who have had a pulmonary embolism feel better and improve their quality of life, even after taking blood thinners.

More Pulmonary Embolism trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment112 (estimated)
SponsorUniversity Hospital, Brest
Academic / other
Locations6 sites (Brest, France and 5 other locations)
StatusRecruiting
StartedMay 11, 2022
Main results expectedFebruary 25, 2027
Study endsFebruary 11, 2028
Registry record updatedJune 16, 2026
Trial IDNCT05015153 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have been treated with anticoagulants for pulmonary embolism and have specific quality of life impairments.

Probably not a fit

Patients with chronic respiratory conditions, severe cardiac insufficiency, or those unable to participate in rehabilitation due to physical or psychological constraints may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of pulmonary rehabilitation (PR) on patients who have experienced a pulmonary embolism (PE) and continue to suffer from dyspnea and reduced quality of life despite anticoagulation treatment. The intervention involves a structured PR program aimed at alleviating symptoms and enhancing overall well-being. Patients eligible for the study are those aged 18 and older who have been treated with anticoagulants for a specified duration and meet certain quality of life criteria. The study aims to provide evidence for the inclusion of PR in the therapeutic management of PE.

Why it matters

Potential benefit: If successful, this approach could significantly improve the quality of life and reduce dyspnea in patients recovering from pulmonary embolism.

How similar studies have gone: While pulmonary rehabilitation is established for chronic respiratory diseases, its application post-pulmonary embolism is less common, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Patient treated with at least 3 months and up to 8 months of anticoagulation for symptomatic EP diagnosed according the ESC and ACCP guidelines.
* Patients who have a PembQol score ≥ 10% and whose total scores for the subgroups Q7+8 (dyspnea) and Q4 (impact of daily life) are ≥ 10%.

Exclusion Criteria:

* Presence of CTEPH according to international guidelines
* Patients treated for acute PE with anticoagulants for more than 8 months
* Active cancer or in remission for less than two years
* Dyspnea post - COVID due to parenchymal injuries
* Post-COVID hyperventilation syndrome without pulmonary vascular perfusion sequelae.
* Physical or psychological inability to undertake PR
* Isolated or more distal segmental PE
* Neuro-muscular disease with PR contraindication.
* Cardiac insufficiency (unstable coronary artery disease)
* Severe respiratory failure (long-term oxygen therapy, pulmonary hypertension)
* Chronic dyspnea MMRC ≥ 2 before PE
* Cardiac or respiratory rehabilitation in the previous year
* Indication to urgent PR within 6 months at the time of inclusion
* Life expectancy of less than 12 months
* Inability to give consent
* Patient under guardianship or curatorship
* Patient deprived of liberty by an administrative or judicial decision
* Patient has not social security affiliation or who don't beneficiary of such social security

Where it's running

  • CHU Brest
    Brest, France, France
    Recruiting
  • CHU Angers
    Angers, France
    Recruiting
  • CHU de Grenoble
    Grenoble, France
    Recruiting
  • CHBS Lorient
    Lorient, France
    Recruiting
  • Hegp (Ap-Hp)
    Paris, France
    Recruiting
  • CHU Saint-Etienne
    Saint-Etienne, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.